Ontology highlight
ABSTRACT: Background
Hope for future treatments to prevent or slow down dementia motivates researchers to strive for ever-earlier diagnoses of Alzheimer's disease (AD) based on biomarkers, even before symptoms occur. But is a biomarker-based early diagnosis desirable in clinical practice?Objective
This study explores the ethical considerations that shape current clinical practice regarding early AD diagnostics and the use of biomarkers.Methods
In this qualitative study, Dutch physicians were interviewed. Topics included physicians' views concerning early AD diagnosis in persons with no or mild cognitive impairment, physicians' considerations regarding current and expected future practices of early AD diagnosis, the use of biomarkers, and the use of the concepts preclinical an
SUBMITTER: Tromp K
PROVIDER: S-EPMC7902965 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature